Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice

An established standard of care for the prevention of venous thromboembolism after major orthopedic surgery has been subcutaneous low-molecular-weight heparin. The non-vitamin K antagonist oral anticoagulant rivaroxaban has demonstrated superior efficacy and similar safety to all tested regimens of...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer-Westendorf, Jan, Mouret, Patrick, Turpie, Alexander GG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209349/
https://www.ncbi.nlm.nih.gov/pubmed/30774472
http://dx.doi.org/10.2147/ORR.S105227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209349/
https://www.ncbi.nlm.nih.gov/pubmed/30774472
http://dx.doi.org/10.2147/ORR.S105227

Ejemplares similares